Literature DB >> 14628116

[Congenital malformations of the brain. 2: Malformations of the corpus callosum and holoprocencephalies].

C Rummeny1, B Ertl-Wagner, M F Reiser.   

Abstract

The corpus callosum is formed between the 7th and the 20th gestational week. If this process is disrupted, partial or complete callosal agenesis may ensue. As large parts of the supra- and infratentorial brain are created during this critical period, associated anomalies need always to be searched for when callosal agenesis is present. Associations with neuro-genetic syndromes also exist. The corpus callosum is generally formed from front to back ("front-to-back rule"). Therefore, a partial callosal agenesis usually involves the posterior portion of the corpus callosum, while a secondary lesion of the corpus callosum does not follow this rule. Holoprosencephalies are a notable exception to this rule, as the frontal part of the corpus callosum is absent in spite of their classification as congenital malformations. They represent a disturbance of the differentiation and cleavage of the prosencephalon with a disruption of the separation of the cerebral hemispheres. Holoprosencephalies can be due to genetic causes, but also to intrauterine infections or other teratogenic causes. The holoprosencephalies are subdivided into alobar, semilobar and lobar holoprosencephalies. This article aims to describe the most important features of callosal agenesis and holoprosencephalies highlighting the respective imaging characteristics.

Entities:  

Mesh:

Year:  2003        PMID: 14628116     DOI: 10.1007/s00117-003-0975-7

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  39 in total

Review 1.  Formation, maturation, and disorders of white matter.

Authors:  A J Barkovich; G Lyon; P Evrard
Journal:  AJNR Am J Neuroradiol       Date:  1992 Mar-Apr       Impact factor: 3.825

Review 2.  Pathogenesis of intracranial lipoma: an MR study in 42 patients.

Authors:  C L Truwit; A J Barkovich
Journal:  AJR Am J Roentgenol       Date:  1990-10       Impact factor: 3.959

3.  The development of the human brain, the closure of the caudal neuropore, and the beginning of secondary neurulation at stage 12.

Authors:  F Müller; R O'Rahilly
Journal:  Anat Embryol (Berl)       Date:  1987

4.  Holoprosencephaly in children: diffusion tensor MR imaging of white matter tracts of the brainstem--initial experience.

Authors:  Sait Albayram; Elias R Melhem; Susumu Mori; S James Zinreich; A James Barkovich; Stephen L Kinsman
Journal:  Radiology       Date:  2002-06       Impact factor: 11.105

Review 5.  Cell migration and neuronal ectopias in the brain.

Authors:  P Rakic
Journal:  Birth Defects Orig Artic Ser       Date:  1975

6.  Development of the cerebrospinal fluid pathway in the normal and abnormal human embryos.

Authors:  K Osaka; H Handa; S Matsumoto; M Yasuda
Journal:  Childs Brain       Date:  1980

Review 7.  Holoprosencephaly: a paradigm for the complex genetics of brain development.

Authors:  E Roessler; M Muenke
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

Review 8.  Holoprosencephaly and septo-optic dysplasia.

Authors:  C R Fitz
Journal:  Neuroimaging Clin N Am       Date:  1994-05       Impact factor: 2.264

9.  [Anatomic MRI study of commissural agenesis and dysplasia of the Telencephalon (Agenesis of the corpus callosum and related anomalies). Clinical correlations and morphogenetic interpretation].

Authors:  C Raybaud; N Girard
Journal:  Neurochirurgie       Date:  1998-05       Impact factor: 1.553

10.  Corpus callosum and limbic system: neuroanatomic MR evaluation of developmental anomalies.

Authors:  S W Atlas; R A Zimmerman; L T Bilaniuk; L Rorke; D B Hackney; H I Goldberg; R I Grossman
Journal:  Radiology       Date:  1986-08       Impact factor: 11.105

View more
  1 in total

Review 1.  [Corpus callosum. Landmark of the origin of cerebral diseases].

Authors:  E Hattingen; M Nichtweiss; S Blasel; F E Zanella; S Weidauer
Journal:  Radiologe       Date:  2010-02       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.